Biocept, Inc.

Biocept, Inc. is dedicated to improving outcomes for metastatic cancer patients by delivering advanced diagnostic testing solutions. Located in San Diego, California, Biocept, Inc. develops and performs clinical laboratory tests aimed at helping patients whose cancer has metastasized to the central nervous system (CNS). Biocept's CNSide™ assay offers enhanced detection and analysis of tumor cells and cell-free DNA from cerebrospinal fluid (CSF). The quantitative results from this assay aid in evaluating a patient’s response to treatment.

Biocept, Inc.'s CLIA-certified and CAP-accredited laboratory provides crucial support to oncologists in managing cancer complications. The company's work answers critical questions such as the presence of tumor in the CSF, potential treatment targets, and trends in treatment response. Biocept, Inc. is committed to making a difference in the lives of cancer patients every day, and also provides RT-PCR based COVID-19 testing to support public health efforts. Biocept, Inc. is located at 9955 Mesa Rim Road, San Diego, California 92121, US.

With a focus on innovation and patient care, Biocept, Inc. continues to advance the field of cancer diagnostics. Biocept, Inc.'s dedication to providing high-quality testing services ensures that physicians have the tools they need to make informed decisions and improve patient outcomes. We invite the manager of Biocept, Inc. to create a customized and exclusive company showcase and product listing on our platform to further highlight their contributions to the biotechnology research industry.